{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:52:40Z","timestamp":1793465560544,"version":"4.5.0"},"reference-count":27,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Different molecular subtypes of hepatocellular adenoma (HCA) can occur at the same time within the same patient, defining inter\u2010tumour heterogeneity (ITH). We describe a series of HCA\u2010ITH cases, most identified in Bordeaux with additional cases contributed by other international centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      ITH\u2010HCA cases were subtyped by immunohistochemistry, confirmed by molecular analysis in most cases. The resulting diagnoses were\n                      <jats:italic>HNF1A<\/jats:italic>\n                      \u2010HCA (H\u2010HCA), inflammatory HCA (IHCA), b\u2010catenin\u2010mutated HCA (b\u2010HCA) involving exon 3 or 7\/8, b\u2010catenin\u2010mutated IHCA (b\u2010IHCA) involving exon 3 or 7\/8, sonic hedgehog HCA (sh\u2010HCA) and unclassified HCA (UHCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 26 patients with ITH\u2010HCA including 17 women; none had underlying liver disease, whereas most men did (8\/9). The largest subgroup comprised 22 patients with IHCA combined with another subtype: H\u2010HCA (five patients); H\u2010HCA and b\u2010IHCA\u2010exon 3 borderline (one patient); b\u2010IHCA\u2010exon 3 (six patients); b\u2010HCA and b\u2010IHCA exon 3 (four patients); b\u2010IHCA\u2010exon7\/8 (two patients); sh\u2010HCA (three patients); UHCA (one patient).<\/jats:p>\n                    <jats:p>\n                      The remaining four patients had sh\u2010HCA combined with UHCA (one patient) or b\u2010IHCA ex3 (one patient), and 2 patients with\n                      <jats:italic>HNF1A<\/jats:italic>\n                      adenomatoses, one with malignant transformation, the other associated with a b\u2010IHCA exon3 progressed to HCC. The largest nodule was a 13\u2009cm IHCA. One of the sh\u2010HCA presented with bleeding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ITH\u2010HCA covers the whole spectrum of the HCA classification. It is rare but poses significant clinical challenges, particularly in terms of identifying those lesions at risk of malignant transformation (b\u2010HCA or b\u2010IHCA exon 3) or bleeding (sh\u2010HCA). Referral to a special tertiary centre is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/his.70298","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:50Z","timestamp":1792640690000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification and relevance of inter\u2010tumour heterogeneity in hepatocellular adenoma according to subtypes and the context"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-0623","authenticated-orcid":false,"given":"Paulette","family":"Bioulac\u2010Sage","sequence":"first","affiliation":[{"name":"Inserm, U1053, Bordeaux University  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3333-3579","authenticated-orcid":false,"given":"Alberto","family":"Quaglia","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-3339","authenticated-orcid":false,"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[{"name":"Institute of Pathology University Hospital Heidelberg  Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7383-1898","authenticated-orcid":false,"given":"Alphonse","family":"Charbel","sequence":"additional","affiliation":[{"name":"Institute of Pathology University Hospital Heidelberg  Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-4685","authenticated-orcid":false,"given":"Uta","family":"Drebber","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Uniklinik K\u00f6ln  K\u00f6ln Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-7967","authenticated-orcid":false,"given":"Nyun Young","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medical Science, Brain Korea 21 Project Yonsei University College of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-0680","authenticated-orcid":false,"given":"Taek","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medical Science, Brain Korea 21 Project Yonsei University College of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-1561","authenticated-orcid":false,"given":"Beate Katharina","family":"Straub","sequence":"additional","affiliation":[{"name":"Institute of Pathology University Medicine Mainz, Johannes Gutenberg University Mainz  Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2607-1734","authenticated-orcid":false,"given":"Brigitte","family":"Le Bail","sequence":"additional","affiliation":[{"name":"Inserm, U1053, Bordeaux University  Bordeaux France"},{"name":"Department of Pathology Pellegrin Hospital  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1375-3979","authenticated-orcid":false,"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[{"name":"Institute of Pathology Lausanne University Hospital and University of Lausanne  Lausanne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0081-8112","authenticated-orcid":false,"given":"Charles","family":"Balabaud","sequence":"additional","affiliation":[{"name":"Inserm, U1053, Bordeaux University  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41575-022-00643-5","article-title":"Benign liver tumours: Understanding molecular physiology to adapt clinical management","volume":"19","author":"Nault JC","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"e_1_2_11_3_1","first-page":"351","article-title":"Hepatic adenomas. classification, controversies, and consensus","volume":"11","author":"Torbenson M","year":"2018","journal-title":"Surg. Pathol."},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2020.11.016","article-title":"Hepatocellular adenomas: Review of pathological and molecular features","volume":"112","author":"Beaufr\u00e8re A","year":"2021","journal-title":"Hum. Pathol."},{"key":"e_1_2_11_5_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153670","article-title":"Etiology, pathogenesis, diagnosis, and practical implications of hepatocellular neoplasms","volume":"14","author":"Hytiroglou P","year":"2022","journal-title":"Cancer"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/his.14605","article-title":"Hepatocellular adenoma: What we know, what we do not know, and why it matters","volume":"80","author":"Bioulac\u2010Sage P","year":"2022","journal-title":"Histopathology"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/bjr\/tqae180","article-title":"Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course","volume":"97","author":"Poetter\u2010Lang S","year":"2024","journal-title":"Br. J. Radiol."},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3748\/wjg.v28.i14.1384","article-title":"Hepatocellular adenoma: Where are we now?","volume":"28","author":"Wang X","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4132\/jptm.2021.02.27","article-title":"Hepatocellular adenomas: recent updates","volume":"55","author":"Kim H","year":"2021","journal-title":"J. Pathol. Transl. Med."},{"key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.17998\/jlc.2025.03.06","article-title":"Insights into hepatocellular adenomas in Asia: Molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risks","volume":"25","author":"Heo S","year":"2025","journal-title":"J. Liver Cancer"},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault JC","year":"2017","journal-title":"Gastroenterology"},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00428-023-03680-w","article-title":"Integrated genotype\u2010phenotype analysis of familial adenomatous polyposis\u2010associated hepatocellular adenomas","volume":"484","author":"T\u00f3th M","year":"2024","journal-title":"Virchows Arch."},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.28638","article-title":"Genotype\u2010phenotype correlation of CTNNB1 mutations reveals different \u00df\u2010catenin activity associated with liver tumor progression","volume":"64","author":"Rebouissou S","year":"2016","journal-title":"Hepatology"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","article-title":"Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry","volume":"46","author":"Bioulac\u2010Sage P","year":"2007","journal-title":"Hepatology"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PAS.0000000000001675","article-title":"Predictive patterns of glutamine synthetase immunohistochemical staining in CTNNB1\u2010mutated hepato\u2010cellular adenomas","volume":"45","author":"Sempoux C","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.29336","article-title":"Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk","volume":"66","author":"Henriet E","year":"2017","journal-title":"Hepatology"},{"key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep4.1514","article-title":"ASS1 overexpression: A Hallmark of sonic hedgehog hepatocellular adenomas; recommendations for clinical practice","volume":"4","author":"Sala M","year":"2020","journal-title":"Hepatol. Commun."},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1007\/s00330-023-10344-5","article-title":"Sonic hedgehog hepatocellular adenoma: Magnetic resonance imaging features and correlation with histology","volume":"34","author":"Ducatel A","year":"2024","journal-title":"Eur. Radiol."},{"key":"e_1_2_11_19_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2026.101778","article-title":"New histopathological terminology for well\u2010differentiated hepatocellular lesions in unusual clinico\u2010pathological scenarios: HCA\u2010like and FNH\u2010like","volume":"8","author":"Sempoux C","year":"2026","journal-title":"JHEP Rep."},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/his.12326","article-title":"Coexistence of inflammatory hepatocellular adenomas with HNF1\u03b1\u2010inactivated adenomas: Is there an association?","volume":"64","author":"Castain C","year":"2014","journal-title":"Histopathology"},{"key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/his.13283","article-title":"Focal \u03b2\u2010catenin mutation identified on formalin\u2010fixed and paraffin\u2010embedded inflammatory hepatocellular adenomas","volume":"71","author":"Saldarriaga J","year":"2017","journal-title":"Histopathology"},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.clinre.2019.03.012","article-title":"Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas","volume":"43","author":"Frulio N","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41379-019-0374-x","article-title":"Malignant transformation of liver fatty acid binding protein\u2010deficient hepatocellular adenomas: Histopathologic spectrm of a rare phenomenon","volume":"33","author":"Putra J","year":"2020","journal-title":"Mod. Pathol."},{"key":"e_1_2_11_24_1","first-page":"46","article-title":"Hepatocellular carcinoma in an inflammatory adenoma with \u03b2\u2010catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1\u03b1","volume":"57","author":"Ridder DA","year":"2019","journal-title":"Z. Gastroenterol."},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jhep.2019.08.004","article-title":"Natural history of liver adenomatosis: A long\u2010term observational study","volume":"71","author":"Barbier L","year":"2019","journal-title":"J. Hepatol."},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00330-020-07434-z","article-title":"Hepatospecific MR contrast agent uptakeon hepatobiliary phase can be used as a biomarker of marked \u03b2\u2010catenin activation in hepatocellular adenoma","volume":"31","author":"Reizine E","year":"2021","journal-title":"Eur. Radiol."},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/liv.13667","article-title":"Unexpected discovery of small HNF1\u03b1\u2010inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours","volume":"38","author":"Balabaud C","year":"2018","journal-title":"Liver Int."},{"key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00428-018-2373-6","article-title":"Hepatocellular nodules in vascular liver diseases","volume":"473","author":"Sempoux C","year":"2018","journal-title":"Virchows Arch."}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70298","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/his.70298","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:54Z","timestamp":1792640694000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.70298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":27,"alternative-id":["10.1111\/his.70298"],"URL":"https:\/\/doi.org\/10.1111\/his.70298","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"2026-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"his.70298"}}